indirubin has been researched along with abemaciclib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liang, C; Liu, C; Qiang, T; Ren, X; Shi, Z; Tian, L; Xing, Y | 1 |
| Abbaszadeh, S; Asadi-Samani, M; Ashrafi-Dehkordi, K; Basati, G; Saffari-Chaleshtori, J | 1 |
1 review(s) available for indirubin and abemaciclib
| Article | Year |
|---|---|
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Female; Humans; Pharmaceutical Preparations; Protein Kinase Inhibitors | 2022 |
1 other study(ies) available for indirubin and abemaciclib
| Article | Year |
|---|---|
Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6.
Topics: Aminopyridines; Antineoplastic Agents; Azepines; Benzimidazoles; Binding Sites; Cell Cycle Checkpoints; Computer Simulation; Cyclin-Dependent Kinase 6; Humans; Hydrogen Bonding; Indoles; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Kinase Inhibitors; Pyrroles | 2019 |